HELIX BIOPHARMA CORP (HBP.CA) Stock Cash Flow
TSX:HBP - Toronto Stock Exchange - CA4229102088 - Common Stock - Currency: CAD
| TTM (2024-10-31) | 2024 (2024-7-31) | 2023 (2023-7-31) | 2022 (2022-7-31) | 2021 (2021-7-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -9.35M | -9.26M | -6.29M | -6.56M | -8.04M | |||
| Depreciation Amortization | 14.00K | 14.00K | 13.00K | 12.00K | 199.00K | |||
| Change In Working Capital | 1.78M | 485.00K | 186.00K | -893.00K | -54.00K | |||
| Other non cash items | 3.30M | 3.55M | 564.00K | 935.00K | -1.41M | |||
| OPERATING CASH FLOW | -4.25M | -5.22M | -5.53M | -6.51M | -9.30M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.00K | -14.00K | -10.00K | N/A | 0.00 | |||
| Other Investing Activity | N/A | N/A | 5.00K | 0.00 | 2.02M | |||
| INVESTING CASH FLOW | 6.00K | -14.00K | -5.00K | 0.00 | 2.02M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | -2.06M | 0.00 | 3.00M | |||
| Stock Issued/Repurchased | 2.82M | 5.51M | 4.15M | 6.21M | 3.56M | |||
| Other Financing Activity | N/A | 0.00 | 999.00K | N/A | 0.00 | |||
| FINANCING CASH FLOW | 2.82M | 5.51M | 3.09M | 6.21M | 6.56M | |||
| Exchange Rate Effect | N/A | N/A | 0.00 | -9.00K | 52.00K | |||
| CHANGE IN CASH | -1.41M | 273.00K | -2.44M | -313.00K | -670.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -4.25M | -5.22M | -5.53M | -6.51M | -9.30M | |||
| Capital Expenditure | -2.00K | -14.00K | -10.00K | N/A | 0.00 | |||
| FREE CASH FLOW | -4.25M | -5.23M | -5.54M | -6.51M | -9.30M | |||
All data in CAD